NYSE:ZBH - Zimmer Biomet Stock Price, Forecast & News

Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

Zimmer Biomet announced a quarterly dividend on Monday, December 16th. Investors of record on Friday, December 27th will be given a dividend of $0.24 per share on Friday, January 31st. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date is Thursday, December 26th. View Zimmer Biomet's Dividend History.

Zimmer Biomet Holdings Inc (NYSE:ZBH) released its quarterly earnings data on Tuesday, November, 5th. The medical equipment provider reported $1.77 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.75 by $0.02. The medical equipment provider earned $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. Zimmer Biomet had a negative net margin of 1.14% and a positive return on equity of 13.71%. The company's revenue for the quarter was up 3.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.63 EPS. View Zimmer Biomet's Earnings History.

Zimmer Biomet is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Zimmer Biomet.

Zimmer Biomet will be holding an earnings conference call on Tuesday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Zimmer Biomet updated its FY19 earnings guidance on Tuesday, November, 5th. The company provided earnings per share (EPS) guidance of $7.75 -7.90 for the period, compared to the Thomson Reuters consensus estimate of $7.82. The company issued revenue guidance of flat to +0.5% to ~$7.9-8.3 billion, compared to the consensus revenue estimate of $7.95 billion.

24 Wall Street analysts have issued 12 month target prices for Zimmer Biomet's shares. Their forecasts range from $108.00 to $187.00. On average, they expect Zimmer Biomet's stock price to reach $154.57 in the next twelve months. This suggests a possible upside of 4.1% from the stock's current price. View Analyst Price Targets for Zimmer Biomet.

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zimmer Biomet in the last year. There are currently 1 sell rating, 3 hold ratings, 18 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Zimmer Biomet.

Press coverage about ZBH stock has been trending somewhat negative this week, InfoTrie reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Zimmer Biomet earned a news sentiment score of -1.4 on InfoTrie's scale. They also assigned headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Zimmer Biomet.

Some companies that are related to Zimmer Biomet include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), Align Technology (ALGN), Steris (STE), DEMANT A S/ADR (WILYY), MSA Safety (MSA), Wound Management Technologies (WNDM), Wright Medical Group (WMGI), Avanos Medical (AVNS), Inogen (INGN), Establishment Labs (ESTA), Sientra (SIEN) and RTI Surgical (RTIX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Zimmer Biomet investors own include AT&T (T), Cisco Systems (CSCO), Walt Disney (DIS), Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Verizon Communications (VZ), Intel (INTC), Bristol-Myers Squibb (BMY), Chevron (CVX) and Home Depot (HD).

Zimmer Biomet's stock is owned by many different of institutional and retail investors. Top institutional investors include Focused Investors LLC (0.43%), Wedge Capital Management L L P NC (0.43%), New York State Teachers Retirement System (0.13%), Heritage Investors Management Corp (0.06%), Deroy & Devereaux Private Investment Counsel Inc. (0.06%) and PGGM Investments (0.05%). Company insiders that own Zimmer Biomet stock include Arthur J Higgins, Aure Bruneau, Betsy J Bernard, Bryan C Hanson, Chad F Phipps, Didier Deltort, Katarzyna Mazur-Hofsaess, Michael J Farrell, Michael W Michelson, Sang Yi, Syed A Jafry and Tony W Collins. View Institutional Ownership Trends for Zimmer Biomet.

ZBH stock was sold by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Focused Investors LLC, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Janney Montgomery Scott LLC, Zurcher Kantonalbank Zurich Cantonalbank, OLD National Bancorp IN, Sciencast Management LP and Reinhart Partners Inc.. Company insiders that have sold Zimmer Biomet company stock in the last year include Aure Bruneau, Chad F Phipps, Didier Deltort and Sang Yi. View Insider Buying and Selling for Zimmer Biomet.

ZBH stock was acquired by a variety of institutional investors in the last quarter, including PGGM Investments, Columbus Circle Investors, Virginia Retirement Systems ET AL, Strs Ohio, Assenagon Asset Management S.A., Arizona State Retirement System, State of Alaska Department of Revenue and Deroy & Devereaux Private Investment Counsel Inc.. Company insiders that have bought Zimmer Biomet stock in the last two years include Arthur J Higgins, Betsy J Bernard, Bryan C Hanson, Michael J Farrell, Michael W Michelson and Syed A Jafry. View Insider Buying and Selling for Zimmer Biomet.

Shares of ZBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ZBH stock can currently be purchased for approximately $148.46.

Zimmer Biomet has a market capitalization of $30.54 billion and generates $7.93 billion in revenue each year. The medical equipment provider earns $-379,200,000.00 in net income (profit) each year or $7.64 on an earnings per share basis. Zimmer Biomet employs 19,000 workers across the globe.View Additional Information About Zimmer Biomet.

The official website for Zimmer Biomet is http://www.zimmerbiomet.com/.

Zimmer Biomet's mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The medical equipment provider can be reached via phone at 574-267-6131 or via email at [email protected]